Davman Technology Services Private Limited - Due diligence report

A 360° intelligence report on Juno Clinic: trust score, financial health, credit view, compliance, directors, growth and distress signals - …

2012-02-13 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
DT Davman Technology Services Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Juno Clinic — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Juno Clinic is assessed as Low Risk with a Trust Score of 86/100. Juno Clinic is an active private limited indian non-government company incorporated in 2012, operating in the Internet sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 24 Jul 2026 from the latest processed filings. Davman Technology Services Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
80/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 80/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 auditor resignation(s) filed - latest: MATHRUDEV & CO on 2017-01-18.
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
ANURAAG SRIVASTAVA 01234567 Director 01/04/2018 6 yrs Approved
DAVESH MANOCHA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2018)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 80
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 14+ years.
Distress signals & risk flags
Outside liabilities up 1.42 in a year.
1 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment82/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view86/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
22 Sep 2023
Director ceased
Shilpa Lakshminarayanan
19 Oct 2022
Director ceased
ARUN KUMAR MENDU
29 Apr 2021
Director ceased
SUNITA WADEKAR BHARGAVA
30 Mar 2018
Securities allotted
346 Preference Shares - 82.38 Lakh raised
02 Nov 2017
Securities allotted
323 Preference Shares - 76.90 Lakh raised
28 Aug 2017
Securities allotted
1104 Preference Shares - 2.63 cr raised
09 Jan 2017
Securities allotted
3343 Preference Shares - 7.96 cr raised
14 Sep 2016
Director ceased
ANURAAG SRIVASTAVA
31 Mar 2016
Share transfer (FY 2016)
1.00000000 shares to ANURAAG
29 Feb 2016
Director appointed
ANURAAG SRIVASTAVA (Director)
Director ceased
SATISH RAMBACHAN BHATIA
13 Feb 2012
Incorporated
Registered with Roc Mumbai I
Director appointed
DAVESH MANOCHA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Prk Rainbow Mri Centre Private Limited U85320TG2019PTC134930 Karimnagar, Telangana, India
Kalpavriksha Healthcare Services Private Limited U74999TN2016PTC111666 Chennai, Tamil Nadu, India
Ivr Institute Of Vision And Research Private Limited U74999TG2018PTC128851 Hyderabad, Telangana, India
Avanta Health Care Private Limited U85320KA2020PTC141186 Bangalore South, Karnataka, India
Dr Krshna Life Sciences Limited U24233KA1994PLC016699 Udupi, Karnataka, India
Shamshree Healthcare (Opc) Private Limited U85320JK2019OPC011179 Jammu, Jammu & Kashmir, India
Aadhavan Siddhashram Private Limited U85100TN2014PTC095403 Chennai, Tamil Nadu, India
Reddys Medical Solutions Private Limited U74900KA2010PTC053737 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Juno Clinic before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Juno Clinic: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 80/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Juno Clinic - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Juno Clinic pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Juno Clinic - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Juno Clinic an active company?

Juno Clinic has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Juno Clinic financially healthy?

Juno Clinic has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Juno Clinic?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Juno Clinic?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Juno Clinic have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Juno Clinic up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Juno Clinic?

Its Credit Risk Score is 80/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.